![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 37, 34549-34555, September 13, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
§¶,
,
,
,
, and
**
From the
Research Center for Radiation Safety,
National Institute of Radiological Sciences, 4-9-1 Anagawa,
Inage-ku, Chiba-shi, Chiba 263-8555, Japan and the
Division of Basic Sciences, Medical Research
Institute, Kanazawa Medical University, Ishikawa 920-0293, Japan
Received for publication, May 28, 2002
| |
ABSTRACT |
|---|
|
|
|---|
NP95, which contains a ubiquitin-like domain, a
cyclin A/E-Cdk2 phosphorylation site, a retinoblastoma (Rb) binding
motif, and a ring finger domain, has been shown to be
colocalized as foci with proliferating cell nuclear antigen in
early and mid-S phase nuclei. We established Np95 nulligous
embryonic stem cells by replacing the exons 2-7 of the
Np95 gene with a neo cassette and by selecting out a
spontaneously occurring homologous chromosome crossing over with a
higher concentration of neomycin. Np95-null cells were more
sensitive to x-rays, UV light,
N-methyl-N''-nitro-N-nitrosoguanidine (MNNG), and hydroxyurea than embryonic stem wild type
(Np95+/+) or heterozygously inactivated
(Np95+/ Entry into and progression through the mammalian cell cycle are
highly regulated processes that involve a number of positively and
negatively acting proteins at the molecular level. When growing cells
are exposed to DNA damage or DNA replication blocks, they arrest their
cell cycle processes, apparently to allow time for repair to be
completed satisfactorily. This arrest is part of a "checkpoint"
function that monitors the physical state of DNA at different stages of
the cycle. Cells that have lost a checkpoint control may be as DNA
damage-sensitive as cells that have lost DNA repair capability. Many
genes are involved in controlling the cell cycle and determining
checkpoints (1-3). Furthermore, a possible link between checkpoint
failure, hypersensitivity to DNA damage or replication blockage, and
genomic instability has provided an important insight into processes
contributing to the cellular dysfunction that leads to cancer (4).
We previously produced a monoclonal antibody, Th-10a
mAb,1 that recognizes a
95-kDa mouse nuclear protein (NP95). NP95 was detected by the Th-10a
mAb, specifically in the S phase of normal mouse thymocytes. In
contrast, mouse T cell lymphoma cells showed a constantly high level
for NP95 accumulation irrespective of cell stages during the cell cycle
(5). By immunoscreening a In this study, to gain further insights into the physiological role of
NP95, we attempted to produce a targeted disruption of mouse
Np95. We made strenuous but ultimately futile efforts to
obtain Np95 null mice, probably because Np95
inactivation caused mid-gestational embryonic lethality. We, therefore,
established Np95-null embryonic stem (ES) cells by treating
Np95+/ Construction of the Np95 Targeting Vector
To construct the targeting vector of Np95, genomic
DNA segments corresponding to the Np95 were obtained by
screening of the strain 129 genomic library, ES Cell Cultures
ES cells, E14, were kindly provided by Dr. Martin L. Hooper (Department of Pathology, University of Edinburgh Medical
School, Edinburgh, Scotland, UK) (10). These were cultured in ES
medium containing Dulbecco's modified Eagle's medium (430-2800ED,
Invitrogen) supplemented with 15% fetal calf serum,
L-glutamine, penicillin-streptomycin, nucleoside mixture
(adenosine, guanosine, thymidine, cytidine and uridine), non-essential
amino acids (Invitrogen), 10 Generation of NP95-deficient ES Cells
E14 cells were grown on embryonic fibroblast feeder cells,
electroporated in the presence of 30 µg of NotI linearized
targeting vector, pNPKO1, and selected on neomycin-resistant
feeder cells with G418 at 125 µg/ml for 7 days. Homologous
recombinants were identified by PCR using primers NC (+)
(AGAGGAGAGTGCGGATCGCCGCCGTGAGAG) in exon 1 and NEO ( PCR Analysis and Southern Blot Analysis for Identification
ES cell colonies surviving for 7 days were trypsinized and grown
for 1.5 days in 96-well plates. The cells were trypsinized and
duplicated. Half of these cells were centrifuged and boiled in 100 µl
of distilled water. A portion of cell lysate (10 µl) was subjected to
30-cycle PCR amplification of homologous recombined allele using the
primer set, exon 1 primer, NC (+), and pgk poly(A) signal primer, NEO
( Western Blotting
3 × 106 ES cells were seeded in 10-cm dishes,
and after 12 h, they were washed twice with PBS(++) and
immediately lysed in lysis buffer (8) plus SDS sample buffer (New
England BioLabs, Beverly, MA). Equal amounts of whole cell lysates
were separated by 4-20% gradient SDS-PAGE (Dai-ichi Pure
Chemicals, Tokyo, Japan) and transferred to Immobilon-P (polyvinylidene
difluoride) membranes (Millipore Co., Bedford, MA). Membranes blocked
in 5% skim milk (DIFCO Laboratories, Detroit, MI) in PBS for 1 h
were rinsed and incubated with anti-NP95 (Th-10a) or anti-PCNA (PC10,
BD PharMingen) antibody in 0.5% skim milk in PBS for 1 h at room
temperature, washed three times with PBS-T (0.1% Tween in PBS).
Binding of primary antibody was revealed using horseradish
peroxidase-coupled anti-rat IgG antibody P0450 (DAKO, Kyoto, Japan)
diluted at 1:5000 in 0.5% skim milk in PBS for 1 h at room
temperature and washed three times with PBS-T. Signals were developed
by enhanced chemiluminescence (Lumi-Light Plus; Roche Molecular Biochemicals).
Flow Cytometric Analysis
Cells were fixed with cold 70% ethanol for 30 min at 0 °C,
washed twice with PBS supplemented with 5% fetal calf serum (FPBS), resuspended with 30 µl of anti-Np95 monoclonal antibody
(Th-10a) in FPBS, and incubated for 1 h at room temperature. The
cells were then washed twice with FPBS and resuspended in fluorescein isothiocyanate-conjugated anti-rat IgG (F234, Dako Japan, Kyoto, Japan). After incubation for 1 h at room temperature, the cells were washed twice with FPBS and subjected to flow cytometric analysis (FACscan, BD PharMingen).
Transfection of Np95 cDNA into Np95-null Cells
Np95 cDNA was inserted into pcDNA 3.1 vector
containing a V5 epitope and His tag (Invitrogen). To construct
pIRES.hyg.Np95.V5HA expression vector, an Np95 cDNA
fragment containing the Kozack sequence in the N terminus and
connected with a V5 epitope and His tag in the C terminus was inserted
into the BamHI site of the pIRES.hyg vector
(CLONTECH). pIRES.hyg.Np95.VA.HA plasmid or empty
vector (pIRES.hyg) were linearized by digestion with FspI,
and 19.4(Np95 In Vitro Treatment
X-irradiation--
ES clones were trypsinized and plated
on gelatin-coated 100-mm dishes (Falcon, BD PharMingen) at a density
ranging from 1.5 × 103 to 6 × 103
per dish. Following incubation at 37 °C for 16 h, ES cells were exposed to various doses of x-rays. Irradiation was performed with a
Shinai-III x-ray generator (Shimadzu Seisakusho Ltd., Kyoto, Japan)
at 0.72 Gy/min (200 kVp (kilovolts at peak), 20 mA, with filters
of 0.5 mm copper and 0.5 mm aluminum).
UV Irradiation--
ES clones were trypsinized, plated on
gelatin-coated 100-mm dishes, and cultured at 37 °C for 16 h.
ES cells were washed twice and then overlaid with 5 ml of
Dulbecco's PBS( MNNG Treatment--
ES clones were trypsinized and plated on
gelatin-coated 100-mm dishes at 1.0-1.5 × 103 cells
per dish. After incubation at 37 °C for 16 h, ES cells were
exposed to various concentrations of MNNG in ES medium for 60 min at
37 °C, washed twice with PBS( HU Treatment--
ES clones were trypsinized and plated on
gelatin-coated 100-mm dishes at 1.5 × 103 cells.
Following incubation for 16 h at 37 °C, ES medium was removed,
and various concentrations of HU (Sigma) were added to the cultures.
After the treatment for 4 h at 37 °C, ES cells were washed with
15 ml of Dulbecco's modified Eagle's medium and cultured further in
ES medium.
Colony Formation
Following these treatments, ES cells were incubated with ES
medium for 7 days, and colonies were scored. Plating efficiencies ranged from 30 to 50%. Relative survivals in terms of the loss of
clonogenicity were based on at least two or three experiments carried
out in triplicate.
Radioresistant DNA Synthesis (RDS) Assay
Twenty thousand ES cells were plated into labeling ES
medium containing 0.02 µCi/ml, [2-14C]thymidine (7 mCi/mmol; PerkinElmer Life Sciences) and were grown for 24 h.
After removal of the radioactive medium, each culture was further
incubated in fresh ES medium for at least another 2 h to
deplete residual 14C-labeled thymidine from endogenous DNA
precursor pools. Cultures were then irradiated with 4 Gy of x-rays. At
specific times during subsequent incubation, the corresponding x-ray-
and sham-treated cell monolayers were pulse-labeled for 1 h with 5 µCi/ml [methyl-3H]thymidine (88.2 Ci/mmol, PerkinElmer
Life Sciences). The paired cultures were rinsed with ice-cold 1× SSC
and lysed with 1 ml of lysis solution (0.05% SDS, 10 mM
EDTA). The lysates were precipitated on wet Whatman GF/C glass filters
followed by addition of 1 ml of 8% perchrolic acid. The filters were
rinsed with ice-cold 4% perchrolic acid, rinsed twice with 70 and
100% ethanol, dried, and counted in a liquid scintillation
spectrometer (Beckman Instruments). The rate of semiconservative DNA
synthesis in irradiated cultures was calculated as follows and
expressed as a percentage of incorporations for sham-treated
controls, as shown in Equation 1,
) cells. Expression of transfected
Np95 cDNA in Np95-null cells restored the
resistance to x-rays, UV, MNNG, or hydroxyurea concurrently to a level
similar to that of Np95+/
cells, although
slightly below that of wild type (Np95+/+)
cells. These findings suggest that NP95 plays a role in the repair of
DNA damage incurred by these agents. The frequency of spontaneous
sister chromatid exchange was significantly higher for
Np95-null cells than for Np95+/+
cells or Np95+/
cells (p < 0.001). We conclude that NP95 functions as a common component in the
multiple response pathways against DNA damage and replication arrest
and thereby contributes to genomic stability.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
gt-11 cDNA expression library with the
Th-10a mAb, we isolated the cDNA encoding NP95 (6). Sequencing of
the whole 3.5-kb cDNA revealed that NP95 is a novel nuclear protein
with an open reading frame consisting of 782 amino acids. The open
reading frame contains an unusual N-terminal domain that bears a
striking resemblance to ubiqutin, a leucine zipper motif, a zinc finger motif, a potential ATP/GTP binding site, a putative cyclin A/E-cdk2 phosphorylation site, retinoblastoma protein (Rb)-binding motifs, and a
ring finger domain (6). NP95 was shown to be localized in S phase
nuclei as dot-like foci (7). Double immunostaining for NP95 and
chromatin-bound PCNA revealed that NP95 was almost exclusively
colocalized with chromatin-bound PCNA throughout the nucleus in early S
phase and partly in mid-S phase. However, distinct localization of the
two proteins became evident in some part in mid-S phase and late-S
phase (7, 8). These results suggested that NP95, rather than committing
DNA replication itself as a component of replication machinery,
contributes to some other DNA replication-linked events (8).
ES cells with a higher concentration of
G418 (2 mg/ml) to select out a mitotic crossing over. We examined the
effect of the homozygous Np95 disruption on the sensitivity
to x-rays, UV light, and
N-methyl-N''-nitro-N-nitrosoguanidine (MNNG) and found that Np95-null ES cells were more sensitive
to treatment with these agents than ES wild type (E14.wt) or
19(Np95+/
) cells. In addition,
Np95-null ES cells turned out to be more sensitive to DNA
replication inhibitor hydroxyurea (HU) than E14.wt or
19(Np95+/
) cells. To obtain further insights
into the role of NP95 in DNA recombination and chromosomal stability,
we examined the frequency of spontaneous sister chromatid exchange
(SCE) in NP95-deficient cells. In view of the characteristics of
NP95-deficient cells, we suggest that NP95 functions as a common
component in the multiple DNA damage response pathways and that it
plays a role in the maintenance of genomic stability.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
129 (9), with 1.8 kb of
N-terminal cDNA of Np95 cDNA. Selected genomic
fragments containing the Np95 gene were subcloned into
pBluescriptII SK (
). Sequencing of each clone was done using
dye terminator beginning with the T3 and T7 ends (GenBankTM
accession number AB066245). The exon-intron boundary predictions were
based upon comparison of the genomic sequence with Np95
cDNA (6). The targeting vector, pNPKO1, was constructed using two genomic clones, pNP1 and pNP7. The upstream 1.5-kb BamHI
fragment from pNP1 and downstream 6.2-kb
SalI/EcoRI fragment from pNP7 were inserted into
sites of restriction enzymes, ClaI and XbaI, in
pgk-Neo cassette. This insertion resulted in deletion from exon 2 to
exon 7 (see Fig. 1A).
4 M
2-mercaptoethanol, and 103 units/ml leukemia
inhibitory factor (ESGRO; ESG1107, Chemicon International) (11), and
then they were maintained in a 5% CO2 humidified
incubator. For labeling experiments, ES medium without nucleoside
supplementation was employed ("labeling ES medium").
)
(GATTCGCAGCGCATCGCCTTCTATCG) in the poly(A) signal of the
pgk-Neo cassette. PCR-positive clones were confirmed with
Southern blots using probe A (300 bp) and probe B
(EcoRI/KpnI fragment outside of pNPKO1).
Heterozygous ES cell lines for the Np95 gene were expanded
for several passages and plated onto 10 gelatin-coated 100-mm dishes at
a density of 1.0 × 106 cell/dish, cultured for
24 h, and grown in the presence of 2 mg/ml of G418. Homozygous
clones that survived for 10 days were identified by Southern blots
using probe A. Inactivation of the Np95 gene was confirmed
by Western blot with Th-10a mAb.
). Amplification was performed with LA Taq polymerase
(TaKaRa Bio, Inc., Kyoto, Japan) as follows: initial 4-min incubation
at 94 °C, 30 cycles consisting of 95 °C for 30 s, 60 °C
for 30 s, and 72 °C for 90 s with a final 5-min elongation step at 72 °C. Genomic DNA isolated from ES cell lines was digested with BamHI, separated by electrophoresis through 0.6%
agarose gel, and transferred to nylon membrane in 2× SSC. The probe
utilized is described in Fig. 1A and was
32P-labeled with random primer labeling kit (TaKaRa Bio,
Inc.). The membrane was washed twice in 2× SSC and analyzed with
Bio-image analyzer BAS2000.
/
) cells were transfected with these
plasmid DNAs using LipofectAMINE 2000 according to instructions
provided by the manufacturer (Invitrogen). The cells were subsequently
cultured for 10 days in the presence of Hygromycin B (70-100 µg/ml,
Invitrogen). Thirty colonies resistant to Hygromycin B were isolated,
and DNA from these colonies was isolated and analyzed to determine
whether the full-length Np95 cDNA was detected by PCR.
Finally, these clones were confirmed to produce NP95 by flow cytometric
analysis following immunostaining of the cells with anti-NP95
mAb(Th-10a) and anti-V5 mAb.
) (Nissui Pharmaceutical, Co. Ltd., Tokyo,
Japan). The cells were irradiated with UV light emitted from germicidal
lamps (15 watts, GL-15, Toshiba, Tokyo, Japan) at room temperature. The
fluence rate was 0.285 J/m2/s as measured with a UV
intensity meter (Topcon UVR-254, Tokyo Kogaku, Tokyo, Japan).
), and then cultured further in ES medium.
(Eq. 1)
SCE Analysis
ES clones were trypsinized and plated on gelatin-coated
25-cm2 flasks (for x-rays and MNNG treatment) and
10-cm2 plates (for UV treatment) at a 1.0 × 106 cell density. After overnight culture, ES medium was
changed, and the cells were treated with x-rays, UV, and MNNG as
described above. The cells were then cultured for approximately two
cell cycle periods (24 h) with ES medium containing 5 µM
bromodeoxyuridine and pulsed with 0.04 µg/ml Colcemid for the final
1 h. The cells were collected by centrifugation and exposed to
0.075 M KCl hypotonic solution for 12 min at 37 °C. The
cells were washed twice with the fixative (methanol:acetic acid = 3:1) and suspended in a small volume of the fixative. The cell
suspension was dropped onto ice-cold wet glass slides and air-dried at
60 °C for 2 h. Sister chromatid differential staining was
obtained by a method described earlier (12, 13). Briefly, the cells on
the 2-day slides were incubated with 0.5 µg/ml Hoechst 33258 in 0.067 M phosphate buffer, pH 7.0, for 10 min, rinsed with 0.067 M PBS (pH 7.0) and then overlaid with coverslips. The
coverslipped slides were exposed to black light (
= 352 nm) at
a distance of 9 cm for 2 h. After removal of coverslips, the
slides were incubated in 2× SSC (0.3 M NaCl plus 0.03 M sodium citrate) solution at 60 °C for 1 h and
then stained with 5% Giemsa solution in 13 mM phosphate
buffer, pH 6.8, for 10 min, rinsed in water, and air-dried. Student's
t test was employed for statistical analyses.
| |
RESULTS |
|---|
|
|
|---|
Generation of NP95-deficient ES Cell Lines--
To further
elucidate the physiological function of NP95, we generated cell lines
with disrupted Np95. Mouse Np95 gene cloned from
the genomic library of strain 129 spans about 23 kb. We constructed a
targeting vector in which part of the Np95 genomic region
from exon 2 containing initiation codon to exon 7 was replaced by a pgk-neo gene cassette (Fig.
1A). After transfection with
electroporation and selection in ES medium containing 125 µg/ml G418,
we isolated 234 G418-resistant ES clones and two clones (No. 19 and No.
169) were homologous recombinants in Np95 genome locus (Fig.
1B). To obtain NP95-deficient ES cells disrupted in both
alleles, heterozygous 19(Np95+/
) clone was
selected in medium containing highly concentrated G418 (2 mg/ml), and 17 resistant clones were isolated. Two clones (19.4 and
19.7) were shown to be mutated in both of the alleles (Fig.
1B). Reverse transcript-PCR analysis (data not shown) and Western blot analysis were performed, and the Np95 gene was
not expressed in these cells (Fig. 1C). Since expression of
NP95 is restricted in S phase cells and co-localized with PCNA (7, 8),
it was assumed that NP95 was associated with DNA replication and that
NP95-deficient ES cells were lethal. However, NP95-deficient ES cell
lines were grown in leukemia inhibitory factor-containing medium, and
the doubling time was 12 h, similar to E14.wt and 19(Np95+/
) cell lines (data not shown).
Plating efficiency of NP95-deficient ES cells was normal. This
indicated that NP95 participates in DNA replication-linked events other
than DNA replication itself as a replication machinery, a finding that
is consistent with a previous observation (8).
|
Hypersensitivity to X-rays, UV, and MNNG--
PCNA is known to be
co-localized with proteins involved in DNA replication, DNA repair, and
cell cycle regulation (14-21, 27). To determine whether deletion of
the Np95 gene affects the DNA repair, we examined the
sensitivity of NP95-deficient ES cells to various types of DNA
damage. E14.wt, 19(Np95+/
), and NP95-deficient
ES cells (19.4(Np95
/
) and
19.7(Np95
/
)) were exposed to various doses
of x-rays, and the survival curve was obtained as shown in Fig.
2. The results indicated that
NP95-deficient ES cells were more sensitive to x-rays than E14.wt cells
or 19(Np95+/
) cells. D37 (the dose
required to reduce the fraction of surviving cells to 0.37) was 1.5 Gy
for Np95
/
cells, 2.4 Gy for
Np95+/
cells, and 3.1 Gy for
Np95+/+ cells. NP95-deficient cells were also
more sensitive to UV light and the alkylating agent, MNNG, than E14.wt
cells. D37 for Np95
/
cells and
E14.wt Np95+/+ cells was ~2.6 J/m2
and 4.7 J/m2 for UV and 4.2 µM and 8.5 µM for MNNG, respectively (Fig.
3, A and B). Thus,
NP95-deficient ES cells exhibited an ~2-fold sensitization to the
three different kinds of DNA damaging agents as compared with E14.wt
cells. The marginal difference in the cytotoxicity between E14.wt cells
and 19(Np95+/
) cells was statistically
significant for 2 and 4 Gy of x-rays but not for 10 and 20 µM of MNNG.
|
|
Complementation Experiment of NP95-deficient ES Cell
Line--
Since NP95-deficient ES cells were shown to be more
sensitive to various DNA damaging agents than ES wild type cells, we
examined whether transfection with Np95 cDNA into
NP95-deficient ES cells could restore the response to DNA damage to a
level similar to that of E14.wt and 19(Np95+/
)
cells. We constructed NP95 expression vector, in which Np95 cDNA connected with a V5 epitope and His tag at the C terminus was
inserted into pIRES.hyg expression vector
(CLONTECH). The NP95 expression construct was
linearized and transfected into 19.4(Np95
/
)
cells. After screening of hygromycin B-resistant clones based on PCR
and flow cytometric analysis, we obtained a considerable number of
stable transfected subclones of 19.4(Np95
/
)
cells. Among these, two Np95-transfected subclones, N2 and N8, were
confirmed to have an intact structure by PCR data and concomitant detection of NP95 protein and V5 epitope. Empty vector-transfected PV-1
cells were subjected to subsequent analyses as a negative control.
The transfection with Np95 cDNA restored the resistance
of 19.4(Np95
/
) cells to x-rays to a
considerable extent, although virtually similar to that of
19(Np95+/
) cells (N2 and N8 in Fig. 2). Less
than complete recoveries to the wild type level of x-ray sensitivity
were unequivocal as the difference in the surviving fraction between N8
and E14.wt was statistically significant; p < 0.02 for
2 Gy, p < 0.001 for 4 Gy. Immunostaining of these
cells against NP95 followed by the fluorescence-activated cell sorter
analysis revealed that the levels of NP95 expression in both N8 and N2
cells gained only about a quarter of those of E14.wt or
19(Np95+/
) (data not shown). These inadequate
levels of NP95 expression in N8 and N2 may explain the insufficient
recovery. The unexpected suppression of NP95 function by the pIRES.hyg
vector itself was ruled out since no difference was observed in the
extent of the hypersensitivity to x-rays between
19.4(Np95
/
) cells and empty
vector-transected PV-1 cells in an independent experiment (data not
shown). Clonogenic survivals after exposure to UV light or MNNG in Np95
cDNA-transfected cells indicated that the cellular resistance to
those agents was also regained, although the extent of recovery was
again incomplete (N2 cells in Fig. 3, A and B).
Empty vector transfection had no effect on the sensitivity of
19.4(Np95
/
) cells to UV or MNNG exposure
(PV-1 cells in Fig. 3, A and B). These results
strongly indicate that Np95 is one of the genes bestowing
cellular resistance concurrently to ionizing radiation (IR), UV, and
MNNG.
Hypersensitivity to HU and Complementation
Experiment--
Expression of a kinase-inactive allele of
ATR (ATRkd) in human fibroblasts caused an
increased sensitivity to IR, methyl methanesulfonate (MMS), and UV
together with an DNA replication inhibitor, HU, and displayed a loss of
checkpoint control (22, 23). Since NP95-deficient cells were also
hypersensitive to x-rays, UV, and MNNG (Figs. 2 and 3, A and
B), it seemed possible to presume that the loss of NP95
likewise results in an increased sensitivity to HU. NP95-deficient ES
cells were indeed more sensitive to HU than either E14.wt cells or
19(Np95+/
) cells (19.4 cells and 19.7 cells in
Fig. 4). Moreover, Np95 cDNA-transfected cells restored the resistance to HU to an extent similar to that of 19(Np95+/
) cells (N8 cells
and N2 cells in Fig. 4). Empty vector-transfected PV-1 cells and
19.4(Np95
/
) cells showed a similar
hypersensitivity to HU exposure, as we had expected. Thus, the
Np95 gene appeared to confer the cellular capability to cope
with DNA replication blocks incurred by HU.
|
Kinetics of DNA Synthesis in ES Cells after X-irradiation-- The cultured skin fibroblasts derived from the patients with ataxia-telangiectasia are sensitive to IR, but such cells show little or no increase in the sensitivity to UV, alkylating agents, or anti-metabolic inhibitors of DNA replication. These cells are also characterized by an enhanced RDS (24-26). On the other hand, the overexpression of a kinase-inactive allele of ATR in human fibroblasts causes an increased sensitivity to IR, UV light, and MMS and abrogates the G2/M arrest after exposure to IR. Although these cells do not show an unequivocal increase in RDS, the induction of an overexpression of wild type ATR in ataxia-telangiectasia fibroblast cells restores the ability to inhibit DNA synthesis after exposure to IR, suggesting a possible overlap between ATM and ATR functions (22).
Since NP95-deficient cells are sensitive to DNA damaging agents and DNA
replication block, we analyzed whether NP95-deficient ES cells possess
the characteristics of an enhanced RDS. We examined the time course of
alterations in post-x-ray DNA synthesis after the exposure of cells to
4 Gy and after cells are pulse-labeled with [3H]thymidine
at various subsequent incubation times. The outcome of a typical
experiment involving NP95-deficient ES cells and control ES cells is
depicted in Fig. 5. In
19.4(Np95
/
) and
19.7(Np95
/
) cells, the replication rate
decreased instantly, reaching a minimal level, i.e.
~35-50% of that of the sham-irradiated samples, at 30 min after
treatment (Fig. 5). This was followed by a 1-2-h recovery phase
whereupon synthesis again declined so rapidly that by 3 h, the
level was only 42-55% of that occurring in undamaged cultures. The
kinetics of post-irradiation DNA synthesis in
19.4(Np95
/
) and
19.7(Np95
/
) cells were almost the same
as those of E14.wt and 19(Np95+/
). The
results indicate that NP95-deficient ES cells are able to inhibit the
initial DNA synthesis after exposure to x-rays, similar to the human
fibroblasts, which overexpressed a kinase-inactive allele of
ATR or wild type ATR.
|
Increased Spontaneous SCE Levels in NP95-deficient ES
Cells--
To investigate the role of NP95 in chromosomal stability,
we compared the spontaneous SCEs in NP95-deficient ES cells with those
in 19(Np95+/
) and E14.wt cells. Fig.
6 presents the histogram of spontaneous sister chromatid exchanges in E14.wt,
19(Np95+/
),
19.4(Np95
/
), and
19.7(Np95
/
) cells. The mean of
SCEs/chromosome for NP95-deficient cells (19.4(Np95
/
) and
19.7(Np95
/
)) was significantly higher than
that for E14.wt and 19(Np95+/
) cells
(p < 0.001). The mean SCE score/chromosome in
19(Np95+/
) cells was not significantly
different from that in wild type E14.wt cells (0.05<p < 0.10). The mean values between
19.4(Np95
/
) cells and
19.7(Np95
/
) cells were also not
significantly different (p > 0.1).
|
| |
DISCUSSION |
|---|
|
|
|---|
In the present study, to further explore the function of NP95, we
established NP95-deficient ES cells by introducing a neo cassette into
exon 2 to exon 7 of the Np95 gene on both alleles and
examined the cellular responses to different kinds of DNA damage
induced by x-rays, UV, and MNNG treatment. Homozygously Np95-inactivated ES cells (Np95-null cells) were
found to be more sensitive to all of these agents than
E14.wt(Np95+/+) or
19(Np95+/
) cells (Fig. 2). Transfection of
Np95-null cells with Np95 cDNA revealed the
ability of the Np95 gene to restore the concurrent resistance to x-rays, UV, or MNNG to almost similar levels as those of
19(Np95+/
) cells, implying that at least part
of the normal response to exposure to IR, UV, or MNNG can be ascribed
to Np95 gene function (Figs. 2 and 3, A and
B). The DNA repair process is itself controlled by a
specific set of genes that encode the enzymes catalyzing cellular
responses to various types of DNA damage. Since Np95-null cells show a similar hypersensitivity to these different kinds of DNA
damage, it is plausible that NP95 plays a common critical role in
different repair processes. Moreover, Np95-null ES cells were hypersensitive to a brief exposure to HU as compared with E14.wt
or 19(Np95+/
) cells (Fig. 4). HU inhibits
ribonucleotide reductase and results in the rapid shrinkage of the
deoxynucleotide triphosphate pools. As these substrates of the DNA
polymerase become exhausted, replication is arrested, and incomplete
synthesis of Okazaki fragments on the lagging strand may give rise to
tracts of persistent single-stranded DNA in close proximity to the
stalled replication fork. The hypersensitivity to HU in
Np95-null cells together with the restoration of HU
resistance by the Np95 cDNA expression in the null cells
clearly suggests that NP95 confers upon cells a capability to cope with
HU-induced lesions at DNA replication.
It has been shown that mutations of Saccharomyces cerevisiae
mec1 or Schizosaccharomyces pombe rad3 render the
yeast hypersensitive to x-rays, UV light, MMS, and HU (28, 29).
Rad3 and mec1 are required for checkpoint
responses to x-rays, UV light, MMS, and HU (30, 31). In addition to
cell cycle checkpoint response, these genes have been implicated in the
regulation of DNA repair (32, 33). Consistent with the hypothesis that
ATR is the structural and functional mammalian homolog of
rad3 and mec1 (30, 34), an overt expression of a
kinase-inactive allele of ATR (ATRkd) in human
fibroblasts has been shown to bring about an increased sensitivity to
-irradiation, MMS, UV, and HU and also to cause a loss of checkpoint
control (22, 23). Liu et al. (35) proposed a model in which
ATM-Chk2 and ATR-Chk1 represent two parallel branches in the mammalian
DNA damage response pathway that respond primarily to different types
of DNA damage. An overexpression of wild type ATR or ATRkd was shown to
correct the aberrant phenotype of RDS in cells defective in ATM
function, suggesting that there may be a functional overlap between ATM
and ATR (22). The initial DNA synthesis in E14.wt,
19(Np95+/
), and Np95-null ES
cells following an exposure to x-irradiation was equally inhibited
regardless of Np95 status (Fig. 5). Thus, it is worthwhile
to note that the phenotype of Np95-null ES cells resembles
that of ATRkd-human fibroblasts or
Chk1
/
cells (22, 23, 35, 36) with
regard to the responsiveness to different types of DNA damage and the
DNA replication inhibitor, HU.
We have demonstrated that NP95 is almost completely colocalized with chromatin-bound PCNA throughout the nuclei in early S phase and also partly in mid-S phase. However, distinct localization of the two proteins in some part becomes evident in mid-S phase and late-S phase (7, 8). Moreover, during meiosis, NP95 is present not only in proliferating spermatogonia but also in meiotic spermatocytes and differentiating spermatids that are not proliferating (7). PCNA has recently been identified as a member of a group of proteins that associate with BRCA1 to form a large complex, BRCA1-associated genome surveillance complex (BASC) (37). On the other hand, ATR has been found to phosphorylate BRCA1 in response to damaged DNA or stalled DNA replication, and so it is conceivable that ATR-BRCA1 complex is required for the maintenance of genomic integrity and for the control of homologous recombination in both somatic and meiotic cells (38-42). Although the interaction between NP95 and PCNA or other repair/replication-related proteins remains to be clarified, we propose that NP95 functions as a component of the complex containing PCNA.
SCE frequency is a commonly used index of chromosomal stability, and
spontaneous chromosomal instability has been correlated with cancer
predisposition (43). Because SCE occurs during and soon after DNA
replication, it is conceivable that SCE takes place when the
replication fork encounters unrepaired lesions and/or affected repair
machineries (44). The endogenously derived lesions presumably cause
SCEs by a mechanism that could also operate for lesions incurred by
extrinsic DNA damaging agents. Such lesions may arise spontaneously as
a consequence of the action of endogenous genotoxins including reactive
oxygen species. Since Np95-null cells are considered to be
defective in some common DNA repair process, unrepaired lesions are
expected to accumulate more abundantly in Np95-null cells
than in E14.wt or 19(Np95+/
) cells. It was
necessary, therefore, to determine whether the lesions responsible for
SCE induction arose more frequently in NP95-deficient cells. The
frequencies of spontaneous SCEs in NP95-null ES cells were
significantly higher than those of E14.wt and
19(Np95+/
) cells (p < 0.001)
(Fig. 6). The frequencies of SCEs following irradiation with 2 Gy of
x-rays were significantly higher in Np95-null cells
(mean (M) ± S.D. and (n) for
19.4(Np95
/
) and
19.7(Np95
/
) were 0.296 ± 0.058 (10)
and 0.278 ± 0.082 (19), respectively) than in E14.wt cells
(0.210 ± 0.10 (15)) and 19(Np95+/
) cells
(0.197 ± 0.090 (17)), although the enhanced SCE-induction by
x-rays in Np95-null cells was not statistically significant.
It has been shown that spontaneous SCE levels are significantly reduced
in chicken DT40 B cells lacking the RAD51 and
RAD54 genes, suggesting that homologous recombination is one
of the principal mechanisms responsible for SCE formation in vertebrate cells (45). On the other hand, spontaneous SCE levels are observed as
being elevated to various extents in cells from patients with Bloom's
syndrome (46), in mouse cells that lack poly(ADP-ribose) polymerase
(47) or KU70 (48), and in hamster cells with deficiency in XRCC1 (49).
Inactivating mutations or disruptions of genes encoding these proteins
have been demonstrated to lead to genomic instability. Although the
frequency of spontaneously arising chromosome aberrations in
NP95-deficient cells remains to be determined, it is highly likely that
NP95 is responsible for the maintenance of chromosomal stability. Taken
together, we propose that NP95 functions as a common component in the
multiple response pathways for DNA damage and that it plays some role
in the maintenance of genomic stability.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. M. L. Hooper (Department of Pathology, University of Edinburgh Medical School, Edinburgh, Scotland, UK) for kindly providing us with E14 ES cells. The excellent technical assistance provided by S. and M. Sasanuma and editorial assistance by Prof. B. Burke-Gaffney are also deeply appreciated.
| |
FOOTNOTES |
|---|
* This work was supported by a Grant for the Project Research "Genetic Control of Biodefense Mechanisms against Radiation" from the Science and Technology Agency, Japan, and in part by a Grant-in-Aid for Scientific Research (Grant 09680540) from the Ministry of Education, Science, Sports and Culture of Japan.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AB066245
§ These authors contributed equally to this study.
¶ Present address: Dept. of Immunology, Kinki University School of Medicine 377-2 Ohno-Higashi, Sayama, Osaka 589-8511, Japan.
** To whom correspondence should be addressed. Tel.: 81-43-206-3091; Fax: 81-43-251-4593; E-mail: tatsumi@nirs.go.jp.
Published, JBC Papers in Press, June 25, 2002, DOI 10.1074/jbc.M205189200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: mAb, monoclonal antibody; MNNG, N-methyl-N''-nitro-N-nitrosoguanidine; ES cell, embryonic stem cell; PCNA, proliferating cell nuclear antigen; HU, hydroxyurea; E14.wt, E14 wild type; SCE, sister chromatid exchange; PBS, phosphate-buffered saline; FPBS, ; PBS-T, 0.1% Tween in PBS; RDS, radioresistant DNA synthesis; Gy, gray; IR, ionizing radiation; MMS, methyl methanesulfonate; ATM, ataxia-telangiectasia-mutated; M, mean.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Elledge, S. J.
(1996)
Science
274,
1664-1672 |
| 2. |
Hartwell, L. H.,
and Weinert, T. A.
(1989)
Science
246,
629-634 |
| 3. | Zhou, B. S., and Elledge, S. J. (2000) Nature 408, 433-439[CrossRef][Medline] [Order article via Infotrieve] |
| 4. |
Hartwell, L. H.,
and Kastan, M. B.
(1994)
Science
266,
1821-1828 |
| 5. | Muto, M., Utsuyama, M., Horiguchi, T., Kubo, E., Sado, T., and Hirokawa, K. (1995) Cell Prolif. 28, 645-657[Medline] [Order article via Infotrieve] |
| 6. | Fujimori, A., Matsuda, Y., Takemoto, Y., Hashimoto, Y., Kubo, E., Araki, R., Fukumura, R., Mita, K., Tatsumi, K., and Muto, M. (1998) Mamm. Genome 9, 1032-1035[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Uemura, T., Kubo, E., Kanari, Y., Ikemura, T., Tatsumi, K., and Muto, M. (2000) Cell Struct. Funct. 25, 149-159[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Miura, M., Watanabe, H., Sasaki, T., Tatsumi, K., and Muto, M. (2001) Exp. Cell Res. 263, 202-208[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Gomi, H., Yokoyama, T., Fujimoto, K., Ikeda, T., Katoh, A., and Itohara, S. (1995) Neuron 14, 29-41[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Hooper, M., Hardy, K., Handyside, A., Hunter, S., and Monk, M. (1987) Nature 326, 292-295[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Itohara, S., Mombaerts, P., Lafaille, J., Iacomini, J., Nelson, A., Clarke, A. R., Hooper, M. L., Farr, A., and Tonegawa, S. (1993) Cell 72, 337-348[CrossRef][Medline] [Order article via Infotrieve] |
| 12. | Perry, P., and Wolff, S. (1974) Nature 251, 156-158[CrossRef][Medline] [Order article via Infotrieve] |
| 13. | Kurihara, T., Inoue, M., and Tatsumi, K. (1987) Mutat. Res. 184, 147-151[Medline] [Order article via Infotrieve] |
| 14. |
Chuang, L. S. H.,
Ian, H.,
Koh, T., Ng, H., Xu, G.,
and Li, B. F. L.
(1997)
Science
277,
1996-2000 |
| 15. |
Humbert, C.,
Santisteban, M. S.,
Usson, Y.,
and Robert-Nicoud, M.
(1992)
J. Cell Sci.
103,
97-103 |
| 16. | Jonsson, Z. O., and Hubscher, U. (1997) Bioessays 19, 967-975[CrossRef][Medline] [Order article via Infotrieve] |
| 17. | Krishna, T. S., Kong, X. P., Gary, S., Burgers, P. M., and Kuriyan, J. (1994) Cell 79, 1233-1243[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | Li, R., Waga, S., Hannon, G. J., Beach, D., and Stillman, B. (1994) Nature 371, 534-537[CrossRef][Medline] [Order article via Infotrieve] |
| 19. |
Morris, G. F.,
and Mathews, M. B.
(1989)
J. Biol. Chem.
264,
13856-13864 |
| 20. |
Stillman, B.
(1996)
Science
274,
1659-1664 |
| 21. | Waga, S., Hannon, G. J., Beach, D., and Stillman, B. (1994) Nature 369, 574-578[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Cliby, W. A., Roberts, C. J., Cimprich, K. A., Stringer, C. M., Lamb, J. R., Schreiber, S. L., and Friend, S. H. (1998) EMBO J. 17, 159-169[CrossRef][Medline] [Order article via Infotrieve] |
| 23. |
Wright, J. A.,
Keegan, K. S.,
Herendeen, D. R.,
Bentley, N. J.,
Carr, A. M.,
Hoekstra, M. F.,
and Concannon, P.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
7445-7450 |
| 24. |
Painter, R. B.,
and Young, B. R.
(1980)
Proc. Natl. Acad. Sci. U. S. A.
77,
7315-7317 |
| 25. | Wit, J. d., Jaspers, N. G. J., and Bootsma, D. (1981) Mutat Res 80, 221-226[Medline] [Order article via Infotrieve] |
| 26. | Kleijer, W. J., Kraan, M. V. D., Los, F. J., and Jaspers, N. G. J. (1994) Int. J. Radiat. Biol. 66, S167-S174[Medline] [Order article via Infotrieve] |
| 27. | Paunesku, T., Mittal, S., Protic, M., Oryhon, J., Korolev, S. V., Joachimiak, A., and Woloshak, G. E. (2001) Int. J. Radiat. Biol. 77, 1007-1021[CrossRef][Medline] [Order article via Infotrieve] |
| 28. | Al-Khodairy, F., and Carr, A. M. (1992) EMBO J. 11, 1343-1350[Medline] [Order article via Infotrieve] |
| 29. |
Desany, B. A.,
Alcasabas, A. A.,
Bachant, J. B.,
and Elledge, S. J.
(1998)
Genes Dev.
12,
2956-2970 |
| 30. | Bentley, N. J., Holtzman, D. A., Flaggs, G., Keegan, K. S., DeMaggio, A., Ford, J. C., Hoekstra, M., and Carr, A. M. (1996) EMBO J. 15, 6641-6651[Medline] [Order article via Infotrieve] |
| 31. |
Weinert, T. A.,
Kiser, G. L.,
and Hartwell, L. H.
(1994)
Genes Dev.
8,
652-665 |
| 32. | Weinert, T. (1998) Cell 94, 555-558[CrossRef][Medline] [Order article via Infotrieve] |
| 33. | Tercero, J. A., and Diffley, J. F. X. (2001) Nature 412, 553-557[CrossRef][Medline] [Order article via Infotrieve] |
| 34. |
Cimprich, K. A.,
Shin, T. B.,
Keith, C. T.,
and Schreiber, S. L.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
2850-2855 |
| 35. |
Liu, Q.,
Guntuku, S.,
Cui, X.,
Matsuoka, S.,
Cortez, D.,
Tamai, K.,
Luo, G.,
Carattini-Rivera, S.,
DeMayo, F.,
Bradley, A.,
Donehower, L. A.,
and Elledge, S. J.
(2000)
Genes Dev.
14,
1448-1459 |
| 36. |
Takai, H.,
Tominaga, K.,
Motoyama, N.,
Minamishima, Y. A.,
Nagahama, H.,
Tsukiyama, T.,
Ikeda, K.,
Nakayama, K.,
Nakanishi, M.,
and Nakayama, K.
(2000)
Genes Dev.
14,
1439-1447 |
| 37. |
Wang, Y.,
Cortez, D.,
Yazdi, P.,
Neff, N.,
Elledge, S. J.,
and Qin, J.
(2000)
Genes Dev.
14,
927-939 |
| 38. | Scully, R., Puget, N., and Vlasakova, K. (2000) Oncogene 19, 6176-6183[CrossRef][Medline] [Order article via Infotrieve] |
| 39. |
Gatei, M.,
Zhou, B. B.,
Hobson, K.,
Scott, S.,
Young, D.,
and Khanna, K. K.
(2001)
J. Biol. Chem.
276,
17276-17280 |
| 40. |
Tibbetts, R.,
Cortez, D.,
Brumbaugh, K. M.,
Scully, R.,
Livingston, D.,
Elledge, S. J.,
and Abraham, R. T.
(2000)
Genes Dev.
14,
2989-3002 |
| 41. | Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., and Livingston, D. M. (1997) Cell 88, 265-275[CrossRef][Medline] [Order article via Infotrieve] |
| 42. |
Chen, J.
(2000)
Cancer Res.
60,
5037-5039 |
| 43. | Roy, S. K., Trivedi, A. H., Bakshi, S. R., Patel, R. K., Shukla, P. H., Patel, S. J., Bhatavdekar, J. M., Patel, D. D., and Shah, P. M. (2000) Cancer Genet. Cytogenet. 118, 52-56[CrossRef][Medline] [Order article via Infotrieve] |
| 44. |
Cleaver, J. E.,
Mitchell, D. L.,
Feeney, L.,
and Afzal, V.
(1996)
Mutagenesis
11,
183-187 |
| 45. |
Sonoda, E.,
Sasaki, M.,
Morrison, C.,
Yamaguchi-Iwai, Y.,
Tanaka, M.,
and Takeda, S.
(1999)
Mol. Cell. Biol.
19,
5166-5169 |
| 46. | German, J., and Ellis, N. A. (1998) in The Genetic Basis of Human Cancer (Vogelstein, B. , and Kinzler, K., eds) , pp. 301-315, McGraw-Hill, New York |
| 47. |
Wang, Z. Q.,
Stingl, L.,
Morrison, C.,
Jantsh, M.,
Los, M.,
Schulze-Osthoff, K.,
and Wagner, E. F.
(1997)
Genes Dev.
11,
2347-2358 |
| 48. | Li, G. C., Ouyang, H., Li, X., Nagasawa, H., Little, J. B., Chen, D. J., Ling, C. C., Fuks, Z., and Cordon-Cardo, C. (1998) Mol. Cell 2, 1-8[CrossRef][Medline] [Order article via Infotrieve] |
| 49. |
Thompson, L. H.,
Brookman, K. W.,
Jones, N. J.,
Allen, S. A.,
and Carrano, A. V.
(1990)
Mol. Cell. Biol.
10,
6160-6171 |